You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

72 search results for: type 2 inflammation

<b>Type</b> <b>2</b> <b>Inflammation</b> Contributes to the Signs and Symptoms of AD and PN
expert video

Type 2 Inflammation Contributes to the Signs and Symptoms of AD and PN

Dermatology
The impact of type 2 inflammation, neuroimmune axis dysfunction, and skin tissue on the signs and symptoms of atopic dermatitis and prurigo nodularis.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> and Cutaneous Manifestation in AD and PN
expert video

Type 2 Inflammation and Cutaneous Manifestation in AD and PN

Dermatology
Pathophysiology of type 2 inflammation in the skin in two distinct, chronic pruritic dermatoses – atopic dermatitis and prurigo nodularis.
View more
PN and AD: Distinct Diseases with Underlying <b>Type</b> <b>2</b> <b>Inflammation</b>
expert video

PN and AD: Distinct Diseases with Underlying Type 2 Inflammation

Dermatology
Prurigo nodularis (PN) and atopic dermatitis (AD): Distinct diseases with underlying type 2 inflammation – highlights from the ADVENT symposium at AAD 2023.
View more
Cutaneous Manifestations in AD & PN: Role of <b>Type</b> <b>2</b> <b>Inflammation</b>
expert video

Cutaneous Manifestations in AD & PN: Role of Type 2 Inflammation

Dermatology
Type 2 inflammation in the distinct cutaneous manifestations of atopic dermatitis and prurigo nodularis – a clip from the ADVENT symposium at AAD 2023.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> and Chronic Pruritus in AD and PN
expert video

Type 2 Inflammation and Chronic Pruritus in AD and PN

Dermatology
Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.
View more
IRS-ISIAN <b>2</b>0<b>2</b>4 | Targeting <b>Type</b> <b>2</b> <b>Inflammation</b>: Managing Smell Loss and Congestion in Patients With Recurrent CRSwNP
expert video

IRS-ISIAN 2024 | Targeting Type 2 Inflammation: Managing Smell Loss and Congestion in Patients With Recurrent CRSwNP

Rhinology
Prof. Joaquim Mullol reports on biologic improvements in sense of smell and nasal congestion in patients with and without a history of endoscopic sinus surgery.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> in CRSwNP: Interactive Patient Case
interactivity

Type 2 Inflammation in CRSwNP: Interactive Patient Case

Rhinology
An interactive patient case tool involving a deep dive into the patient perspective of living with CRSwNP.
View more
Neuroimmune Axis Dysregulation and <b>Type</b> <b>2</b> <b>Inflammation</b>: Shared Roles in AD, PN, and CSU
expert video

Neuroimmune Axis Dysregulation and Type 2 Inflammation: Shared Roles in AD, PN, and CSU

Dermatology
Exploration of the shared type 2 inflammation and neuroimmune axis dysfunction in AD, PN, and CSU leading to itch.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> and Neuronal Sensitization in AD and PN
interactivity

Type 2 Inflammation and Neuronal Sensitization in AD and PN

Dermatology
Mechanisms of itch in normal skin and the effect of type 2 inflammation on neurons leading to chronic itch in atopic dermatitis and prurigo nodularis.
View more
EoE Burden and Pathophysiology of <b>Type</b> <b>2</b> <b>Inflammation</b>
videoanimation

EoE Burden and Pathophysiology of Type 2 Inflammation

Gastroenterology
Learn about the significant burden that patients with EoE experience and the role of type 2 inflammation in this chronic, progressive disease.
View more
What Do We Know About <b>Type</b> <b>2</b> <b>Inflammation</b> in COPD?
expert video

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology
Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.
View more
Effect of <b>Type</b> <b>2</b> <b>Inflammation</b> on Skin Barrier Function in AD​
interactivity

Effect of Type 2 Inflammation on Skin Barrier Function in AD​

Dermatology
Gain insights on how type 2 inflammation affects different aspects of skin barrier function – an interactive educational tool.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region